跳至主要内容
临床试验/NCT06784375
NCT06784375招募中不适用

Individualized Diabetes Education Assisted by CGM (IDEA-CGM)

University of Minnesota2 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2025年7月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
72
试验地点
2
主要终点
Hemoglobin A1c

研究概览

简要总结

This project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 18 years of age
  • previous diagnosis of T2DM
  • HbA1c of 6.8-8.5%

排除标准

  • type 1 diabetes mellitus
  • treatment with insulin, sulfonylurea, or meglitinide
  • use of nondiabetic medications that affect blood glucose control (such as corticosteroids)
  • BMI <25 kg/m2 or <23 kg/m2 for participants who self-identify as Asian
  • weight change >5 pounds in the 3 months prior to study enrollment
  • estimated glomerular filtration rate <60 ml/minute/1.73 m2
  • pregnancy or immediate plans to become pregnant 8) breastfeeding 9) anemia (which would affect measurement of HbA1c) 10) changes to glucose lowering medications, including change in dose, in the 3 months prior to enrollment 11) presence of any disease that would make adherence to the protocol difficult."

研究组 & 干预措施

Blinded CGM/No Nutrition Therapy

Experimental

干预措施: Blinded CGM/No Nutrition Therapy (Behavioral)

Unblinded CGM/No Nutrition Therapy

Experimental

干预措施: Unblinded CGM/No Nutrition Therapy (Behavioral)

Unblinded CGM/Nutrition Therapy

Experimental

干预措施: Unblinded CGM/Nutrition Therapy (Behavioral)

Blinded CGM/Nutrition Therapy

Experimental

干预措施: Blinded CGM/Nutrition Therapy (Behavioral)

结局指标

主要结局

Hemoglobin A1c

时间窗: 12 weeks

Measure of blood glucose control

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验